Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
NCT02251197 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 97
Last updated 2014-09-29
Summary
The objective of this study is to assess the safety, tolerability and pharmacokinetic characteristics of BIII 890 after intravenous infusion in acute ischemic stroke patients.
Conditions
Interventions
- DRUG
-
BIII 890 CL
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-07-31
- Primary Completion
- 2002-10-31
More Related Trials
-
Study Evaluating Single Ascending Doses Of ILS-920
NCT00827190 ·Status: COMPLETED ·Phase: PHASE1
-
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
NCT07252544 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
NCT03062397 ·Status: UNKNOWN ·Phase: PHASE2
-
SY007 in Patients With Acute Ischemic Stroke
NCT04891913 ·Status: SUSPENDED ·Phase: PHASE1
-
Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
NCT01221246 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy
NCT03198715 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
NCT02730455 ·Status: COMPLETED ·Phase: PHASE2
-
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
NCT05199194 ·Status: RECRUITING ·Phase: PHASE3
-
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
NCT01273467 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS
NCT04091945 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Escalating Repeat IV, in Stroke Patients
NCT00833989 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
NCT05156827 ·Status: WITHDRAWN ·Phase: PHASE2
-
Beta Blockers In Acute Ischemic Stroke
NCT01061190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
NCT03290560 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
NCT02586233 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
NCT01208233 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
NCT06571149 ·Status: RECRUITING ·Phase: PHASE4
-
Citicoline in Ischemic Stroke, a Randomized Trial
NCT06210646 ·Status: COMPLETED ·Phase: PHASE3
-
Imatinib in Acute Ischaemic Stroke
NCT03639922 ·Status: UNKNOWN ·Phase: PHASE3
-
The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
NCT00868283 ·Status: COMPLETED ·Phase: PHASE4
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Neuroprotection in Acute Ischemic Stroke
NCT03320018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Mildronate for Acute Ischemic Stroke
NCT01800357 ·Status: UNKNOWN ·Phase: PHASE2
-
Repinotan in Patients With Acute Ischemic Stroke
NCT00044915 ·Status: COMPLETED ·Phase: PHASE2